View Older Stories

Apr 27, 2026 02:52PM Compass Therapeutics (CMPX) PT Lowered to $6 at Stifel

Apr 27, 2026 11:50AM H.C. Wainwright on Compass Therapeutics (CMPX): 'we do believe the probability of a path forward is meaningfully higher than the market reaction observed'

Apr 27, 2026 10:20AM Leerink on Compass Therapeutics (CMPX): 'there are multiple sources of long-term upside'

Apr 27, 2026 08:27AM Stifel on Compass Therapeutics (CMPX): 'Path Forward Complicated by FDA’s “Imply-No-Harm” Mandate'

Apr 27, 2026 08:15AM Compass Therapeutics stock plunges on trial data concerns, William Blair comments

Apr 27, 2026 08:08AM William Blair on Compass Therapeutics (CMPX) 75% Drop: 'This will raise questions on the approvability of this dataset'

Apr 20, 2026 04:29AM Increasing unusual option volume: CMPX IVZ BKLN UTHR KIE ORBS BMEA SGHC

Apr 15, 2026 06:27AM Increasing unusual option volume: CMPX ALLO GSAT CTRA CORN IDYA

Mar 31, 2026 07:32AM Compass Therapeutics (CMPX) Reiterated at Buy by Stifel Ahead of April Disclosure

Mar 12, 2026 09:32AM Cantor Fitzgerald Reiterates Overweight Rating on Compass Therapeutics (CMPX) Ahead of PFS/OS Readout

Mar 9, 2026 05:24AM Compass Therapeutics (CMPX) Reiterated at Market Outperform by Citizens

Mar 5, 2026 05:32PM Compass Therapeutics, Inc. (CMPX) Tops Q4 EPS by 1c

Mar 5, 2026 04:33PM Compass Therapeutics (CMPX) PT Raised to $9 at Jefferies

Mar 5, 2026 11:37AM William Blair Reiterates Outperform Rating on Compass Therapeutics (CMPX)

Mar 5, 2026 11:18AM Raymond James Reiterates Outperform Rating on Compass Therapeutics (CMPX) following Q4 results

Feb 13, 2026 09:03AM Craig-Hallum Starts Compass Therapeutics (CMPX) at Buy

Feb 4, 2026 06:27AM Compass Therapeutics (CMPX) PT Raised to $13 at Canaccord Genuity

Jan 7, 2026 04:10AM Compass Therapeutics (CMPX) Reiterated at Market Outperform by Citizens

Jan 6, 2026 01:40PM Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)

Jan 6, 2026 10:11AM Raymond James Reiterates Outperform Rating on Compass Therapeutics (CMPX)

Jan 6, 2026 08:01AM Compass Therapeutics reports $209 million cash, appoints new executives

Jan 5, 2026 08:01AM Compass Therapeutics names new commercial and medical officers

Jan 5, 2026 04:31AM William Blair Starts Compass Therapeutics (CMPX) at Outperform

Dec 30, 2025 04:05PM Compass Therapeutics, Inc (CMPX) files $400M mixed shelf

Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note

Dec 3, 2025 06:07AM Cantor Fitzgerald Starts Compass Therapeutics (CMPX) at Overweight

Dec 3, 2025 05:15AM Canaccord Genuity Starts Compass Therapeutics (CMPX) at Buy

Dec 3, 2025 03:16AM Citizens Starts Compass Therapeutics (CMPX) at Market Outperform

Nov 4, 2025 09:01AM Compass Therapeutics presents preclinical data for cancer bispecific antibody

Aug 18, 2025 06:34AM Piper Sandler on Compass Therapeutics (CMPX): 'Early '8371 Responses Are Super Interesting'

Aug 12, 2025 07:04AM Compass Therapeutics (CMPX) PT Raised to $12 at Guggenheim

Aug 11, 2025 04:27PM Compass Therapeutics (CMPX) PT Raised to $7 at Leerink Partners

Aug 11, 2025 01:58PM Raymond James Reiterates Outperform Rating on Compass Therapeutics (CMPX)

Aug 11, 2025 07:46AM Compass Therapeutics, Inc. (CMPX) Misses Q2 EPS by 2c

Jul 14, 2025 09:59AM Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)

Jul 1, 2025 06:24AM Raymond James Resumes Compass Therapeutics (CMPX) at Outperform

May 8, 2025 05:29PM Compass Therapeutics, Inc. (CMPX) Misses Q1 EPS by 1c

Apr 29, 2025 07:28AM H.C. Wainwright Reiterates Buy Rating on Compass Therapeutics (CMPX)

Apr 22, 2025 07:06AM H.C. Wainwright Reiterates Buy Rating on Compass Therapeutics (CMPX)

Apr 21, 2025 08:00AM Compass Therapeutics (CMPX) Announces First Patient Dosed in an Investigator Sponsored Trial of Tovecimig in the First-Line Setting for Patients with Biliary Tract Cancer

Apr 2, 2025 06:49AM Leerink Partners Upgrades Compass Therapeutics (CMPX) to Outperform

Apr 1, 2025 07:01AM Compass Therapeutics, Inc (CMPX) Reports CTX-009 Meets Primary Endpoint in the Ongoing Randomized Phase 2/3 Study

Mar 31, 2025 04:07PM Compass Therapeutics (CMPX) to Host Webcast Highlighting Top-Line Clinical Data from the Ongoing Randomized Phase 2/3 Study Evaluating Tovecimig in Patients with Biliary Tract Cancer

Mar 10, 2025 04:31PM Stifel Reiterates Buy Rating on Compass Therapeutics (CMPX)

Feb 28, 2025 04:39AM Compass Therapeutics, Inc. (CMPX) Misses Q4 EPS by 1c

Feb 19, 2025 04:05AM Piper Sandler Starts Compass Therapeutics (CMPX) at Overweight

Jan 8, 2025 08:04AM Compass Therapeutics (CMPX) Provides Corporate Update and Announces Advancement of a New Drug Candidate

Dec 10, 2024 08:12AM Compass Therapeutics (CMPX) Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer

Nov 12, 2024 08:01AM Compass Therapeutics, Inc. (CMPX) Tops Q3 EPS by 3c

Sep 16, 2024 06:49AM Ladenburg Thalmann Upgrades Compass Therapeutics (CMPX) to Buy

View Older Stories